Integrated Bedside Assessment and Prognosis in Hospitalized Patients With Metastatic Cancer

This prospective observational cohort study aims to evaluate whether integrated bedside assessment of handgrip strength, cachexia-related indices, body composition, and patient-reported outcomes improves short-term prognostic stratification in hospitalized patients with metastatic cancer. Handgrip strength is a simple, rapid, and non-invasive measure of muscle function and physical reserve, and it is increasingly recognized as an indicator of frailty, sarcopenia, nutritional status, and cancer cachexia. In addition to handgrip strength, this study evaluates the prognostic value of the handgrip strength-cachexia index, bioelectrical impedance analysis-derived body composition parameters, the CRP-triglyceride-glucose index, and validated patient-reported outcome measures. The study will examine whether these admission-time assessments are associated with 30-day all-cause mortality, 90-day all-cause mortality, and 30-day unplanned hospital readmission.

NCT Number	NCT07167082
Lead Sponsor	Ankara Etlik City Hospital
Conditions	Cancer, Hospitalizations, Sarcopenia, Cachexia; Cancer; Sarcopenia
Enrollment	233 participants
Start Date	2024-09-01
Primary Completion	2025-03-25 (estimated)
Study Completion	2025-03-25 (estimated)
Updated on ClinicalTrials.gov	2026-07-01